STOCKHOLDERS' EQUITY - Narrative (Details) - OmicEra diagnostics acquisition - USD ($) shares in Millions, $ in Millions	1 Months Ended
May 31, 2022	May 01, 2022
Subsidiary or Equity Method Investee [Line Items]
Business acquisition, equity interest issued or issuable (in shares)	0.3
Fair value of stock issued in acquisition		$ 14.8

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=exas_OmicEraDiagnosticsAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: